AbCellera Biologics ABCL
NASDAQ ABCL
$12.24 +0.53 (+4.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Short-Term Debt repayments (2020)

Updated

AbCellera Biologics' Short-Term Debt repayments came in at $387,000 for Q1 2020.

Analysis

AbCellera Biologics (ABCL) Short-Term Debt repayments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 AbCellera Biologics 3.74 Bn 3.20 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 387,000.00
API Access

AbCellera Biologics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=ABCL&period=max&api_key=YOUR_API_KEY